JP2010533735A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010533735A5 JP2010533735A5 JP2010517190A JP2010517190A JP2010533735A5 JP 2010533735 A5 JP2010533735 A5 JP 2010533735A5 JP 2010517190 A JP2010517190 A JP 2010517190A JP 2010517190 A JP2010517190 A JP 2010517190A JP 2010533735 A5 JP2010533735 A5 JP 2010533735A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- peptide
- seq
- fragment
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 13
- 210000004443 dendritic cell Anatomy 0.000 claims 7
- 239000012634 fragment Substances 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 102000014914 Carrier Proteins Human genes 0.000 claims 2
- 108010078791 Carrier Proteins Proteins 0.000 claims 2
- 102000000763 Survivin Human genes 0.000 claims 2
- 108010002687 Survivin Proteins 0.000 claims 2
- 150000001413 amino acids Chemical group 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 230000002163 immunogen Effects 0.000 claims 2
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 230000024932 T cell mediated immunity Effects 0.000 claims 1
- 230000005907 cancer growth Effects 0.000 claims 1
- 229960001438 immunostimulant agent Drugs 0.000 claims 1
- 239000003022 immunostimulating agent Substances 0.000 claims 1
- 230000003308 immunostimulating effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000002271 resection Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96120607P | 2007-07-19 | 2007-07-19 | |
| US60/961,206 | 2007-07-19 | ||
| PCT/US2008/070496 WO2009012460A1 (en) | 2007-07-19 | 2008-07-18 | Survivin peptides as cancer vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010533735A JP2010533735A (ja) | 2010-10-28 |
| JP2010533735A5 true JP2010533735A5 (enExample) | 2011-07-21 |
| JP5438676B2 JP5438676B2 (ja) | 2014-03-12 |
Family
ID=40260098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010517190A Active JP5438676B2 (ja) | 2007-07-19 | 2008-07-18 | 癌ワクチンとしてのサバイビンペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7943138B2 (enExample) |
| EP (1) | EP2178548B1 (enExample) |
| JP (1) | JP5438676B2 (enExample) |
| KR (1) | KR101585042B1 (enExample) |
| CN (1) | CN101754768B (enExample) |
| CA (1) | CA2694011C (enExample) |
| ES (1) | ES2529193T3 (enExample) |
| WO (1) | WO2009012460A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006034334A2 (en) | 2004-09-21 | 2006-03-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response |
| ES2711504T3 (es) * | 2009-07-24 | 2019-05-06 | Rhode Island Hospital | Vacunas de células dendríticas para tumores que expresan asparaginil-beta-hidroxilasa |
| EP4159226A1 (en) | 2010-08-24 | 2023-04-05 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines |
| HUE056350T2 (hu) | 2012-05-16 | 2022-02-28 | Stemline Therapeutics Inc | Rákos õssejt célzott rák elleni vakcinák |
| JP6836400B2 (ja) | 2014-03-28 | 2021-03-03 | ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャリゼーション | 乳がんおよび卵巣がんワクチン |
| MX392412B (es) | 2015-08-10 | 2025-03-24 | Toray Industries | Polipéptidos que tienen actividad inductora de inmunidad. |
| US10167340B2 (en) | 2015-09-04 | 2019-01-01 | Health Research, Inc. | Anti-survivin antibodies for cancer therapy |
| GB201604755D0 (en) * | 2016-03-21 | 2016-05-04 | Vaxeal Res Sas | Immunogenic compositions |
| WO2025159614A1 (ko) * | 2024-01-23 | 2025-07-31 | 한양대학교 산학협력단 | 데옥시콜산과 연결된 암항원 펩타이드를 포함하는 나노구조체 및 이의 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| US7892559B2 (en) * | 2002-01-30 | 2011-02-22 | Survac Aps | Survivin-derived peptides and use thereof |
| WO2005115447A2 (en) * | 2004-05-25 | 2005-12-08 | The Trustees Of The University Of Pennsylvania | Human anti-cancer immunotherapy |
| US20070104689A1 (en) * | 2005-09-27 | 2007-05-10 | Merck Patent Gmbh | Compositions and methods for treating tumors presenting survivin antigens |
-
2008
- 2008-07-18 EP EP08796301.3A patent/EP2178548B1/en active Active
- 2008-07-18 CN CN2008800252039A patent/CN101754768B/zh active Active
- 2008-07-18 JP JP2010517190A patent/JP5438676B2/ja active Active
- 2008-07-18 US US12/176,052 patent/US7943138B2/en active Active
- 2008-07-18 ES ES08796301.3T patent/ES2529193T3/es active Active
- 2008-07-18 WO PCT/US2008/070496 patent/WO2009012460A1/en not_active Ceased
- 2008-07-18 KR KR1020107002216A patent/KR101585042B1/ko active Active
- 2008-07-18 CA CA2694011A patent/CA2694011C/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010533735A5 (enExample) | ||
| EP2583976A3 (en) | Peptide vaccines with SEQ ID NO: 210, 196, 202, 213, 214, 214 or 223 for cancers expressing tumor-associated antigens | |
| RU2020113032A (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии рака легких, в том числе немелкоклеточного рака легких (нмрл) и других видов рака | |
| PH12019502194A1 (en) | Novel immunotherapy against several tumors including gastrointestinal and gastric cancer | |
| NZ620441A (en) | Pcsk9 vaccine | |
| WO2008140621A3 (en) | Transgenic oncolytic viruses and uses thereof | |
| NZ608972A (en) | Engineered nucleic acids and methods of use thereof | |
| JP2010519176A5 (enExample) | ||
| UA110599C2 (uk) | Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку | |
| JP2010540453A5 (enExample) | ||
| NZ601818A (en) | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers | |
| UA110806C2 (uk) | Мікобактеріальна антигенна композиція | |
| RU2010125605A (ru) | Антитело против глипикана-3 с улучшенными кинетическими показателями в плазме | |
| JP2008530975A5 (enExample) | ||
| AR049177A1 (es) | Polipeptidos y conjugados de interferon-alfa | |
| JP2017523985A5 (enExample) | ||
| CN103804482B (zh) | 一种抗菌肽及其应用 | |
| CN107760716A (zh) | 草鱼呼肠孤病毒s11基因真核表达重组质粒的制备方法及其作为核酸疫苗的应用 | |
| JP2014527801A5 (enExample) | ||
| RU2013126628A (ru) | Иммуномодулирующие способы и системы для лечения и/или предотвращения аневризм | |
| MX2007008980A (es) | Acidos nucleicos para apoptosis de celulas cancerigenas. | |
| CN102304484A (zh) | 金丽假交替单胞菌新菌株及其应用 | |
| RU2013111675A (ru) | Рекомбинантный fc-гибридный белок пятого домена фибронектина типа iii dcc | |
| JP2015529629A5 (enExample) | ||
| Zhou et al. | Dendritic cell‐hitchhiking in vivo for vaccine delivery to lymph nodes |